Vollständige Version anzeigen : Altair Nanotechnologies
Nanotechnologies Advances New Pharmaceutical
Altair
Altair’s New Drug For Kidney Dialysis Patients To Be Compared To Competitive Products
RENO, NEVADA, August 1, 2002 - Altair Nanotechnologies Inc. (Nasdaq:ALTI) today announced that it has signed a confidential disclosure agreement (“CDA”) with a major pharmaceutical company. Under the terms of the agreement Altair will present data pertaining to its new pharmaceutical/new chemical entity (“NCE”) for the treatment of elevated phosphate levels in kidney dialysis patients. Altair will provide the initial comparisons of its NCE, a phosphate-binding drug, to other materials currently available in the pharmaceutical marketplace. This comparison will include Forsenol™, a product from Shire Pharmaceuticals Group that is currently pending FDA approval.
Altair’s initial laboratory tests indicated that its NCE displayed certain advantages when compared to the competitive drugs tested. Biological tests will have to be performed to show if these advantages are also significant in animals and humans. According to information published by AnorMED, the worldwide market for phosphate binders for chronic renal failure patients is currently estimated to be $400 million to $600 million.
“We are pleased to have our first CDA signed just two weeks after announcing our new products pertaining to the pharmaceutical industry,” commented Altair President Dr. Rudi E. Moerck. “ We are currently in negotiations with another major pharmaceutical company for the signing of our second CDA and our management team is developing a third CDA with a large company specializing in renal dialysis equipment. We believe our new ceramic compounds have the added potential advantage of possibly being used to bind phosphate directly in a dialysis device during kidney dialysis. To date the binding of phosphate during kidney dialysis has not been successfully demonstrated by any company.”
Altair Nanotechnologies is not a pharmaceutical company; therefore, the company is actively seeking partners to develop its new drug delivery system for an existing pharmaceutical as well as its new phosphate-binding drug into commercial pharmaceuticals. According to Dr. Moerck, the company is encouraged by the interest already shown by three major pharmaceutical companies. The company’s next step is to issue evaluation licenses from which Altair can derive revenues and progress payments. “Our strategy is to grant several evaluation licenses or possibly one exclusive license,” continued Dr. Moerck. “The direction taken will depend on several factors including the speed and ability of a licensee to bring the product to market and the potential short term and long term revenue yield.”
ALTAIR NANOTECHNOLOGIES, INC.
Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterial technology and nanomaterials worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com
Forward-Looking Statements
This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company's actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, biological testing of the pharmaceuticals may not be successful, the pharmaceuticals may not obtain FDA approval and Altair, without the assistance of a strategic partner, may not be capable of funding the FDA approval cycle. Additionally, the company may be unable to attract additional customers, fund additional research or product development through its sales and branding campaign. The company may never earn sufficient revenues to be profitable; its nanoparticle products may not be integrated into any major market groups and products. In addition, other risks are identified in the company's most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events.
# # # #
:confused:
ALTAIR NANOTECHNOLOGIES INC - Nasdaq National Market: ALTI
Share Related
Market Cap(Mil.) 11,800.32
% Held by Institutions 0
Common Shares Outst. 24,584
Average Daily Volume 85,000
Earnings
Latest Report -0.06
Last 12 Months 0.36
Der Chart sieht sehr bescheiden aus und der Kurs für ein Smal Cap an der NASDQ richtig im Keller. Wie ich aus den Staaten hörte braucht die Firma dringend Geld und versucht dort aber auch hier in Deutschland eine Kapitalerhöhung von 3 Mio $. So wie ich erfahren konnte entfallen davon 1,5 Mio auf Deutschland.
Kann mir nicht vorstellen, daß ALTI damit Erfolg haben könnte, denn erstens haben wir eigene sehr gute Nanotec Firmen und zweitens unsere eigenen Probleme.
Wie kann man denn bei 0,65 cts per Aktie eine Kapitalerhöhung planen, da investiert doch kein Mensch in der heutigen Zeit.
Das die Amis es aber auch nie begreifen, wie man in einen europäischen Markt kommt. Nicht mit Finanzplänen, sondern mit erfolgreichen Kooperationen, Präsents und positiver Presse. Dann findet man auch wieder dt. Investoren.
Ich bin mal gespannt ob dies erreicht wird, oder der Vertrieb in irgendeinem Boilerroom landet und Privat Investoren gesucht werden. Also Vorsicht! Obwohl ich die Firma persönlich gar nicht schlecht finde, nur leuchtet mir deren Strategie nicht so ganz ein.
McLeod
Altair Nanotechnologies Purchases Its Reno Production Facility From BHP Billiton
Terms of the Purchase Agreement Cancelled Royalty Payment to BHP
RENO, NV – August 19, 2002 – Altair Nanotechnologies Inc. (Nasdaq: ALTI) today announced that it has purchased an approximately 90,000 square foot building currently housing its corporate offices, laboratories and nanomaterials production facility from BHP Minerals International Inc. (“BHP”), a subsidiary of Australia-based BHP Billiton Limited, for $3 million U.S. Under the terms of the agreement, the first payment is due in 42 months; interest will begin to accrue in 36 months at seven percent per year. Additional terms of the agreement cancelled a three percent royalty payment due BHP on all materials manufactured utilizing the technology purchased by Altair from BHP.
“This is an extremely positive development for Altair,” commented Altair Nanotechnologies President Dr. Rudi Moerck. “The cancellation of all royalty payments significantly enhances Altair’s opportunity to license the patented technology for the manufacturing of titanium dioxide pigment.
“Additionally,” continued Moerck, “owning our building is a significant benefit to the company. Not only does it permit us to reduce certain overhead costs, ownership allows the company to recoup any future expansion investments. The facility was completely renovated by BHP Billiton in 1993 to facilitate research and development and is prepared for nanomaterial production at a 200 ton per year rate. The facility could ultimately accommodate production at a 1,500 ton per year rate.”
ALTAIR NANOTECHNOLOGIES INC.
Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterials and technology worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, batteries, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation. For additional information on Altair and its nanoparticle materials, visit www.altairnano.com
Forward-Looking Statements
This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the company's actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, biological testing of the pharmaceuticals may not be successful, the pharmaceuticals may not obtain FDA approval and Altair, without the assistance of a strategic partner, may not be capable of funding the FDA approval cycle. Additionally, the company may be unable to attract additional customers, fund additional research or product development through its sales and branding campaign. The company may never earn sufficient revenues to be profitable; its nanoparticle products may not be integrated into any major market groups and products. In addition, other risks are identified in the company's most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in company expectations or results or any change in events
ALTAIR NANOTECHNOLOGIES AWARDED PATENT FOR
ITS NANO-SIZED TITANIUM DIOXIDE
New Patent Basis for High Quality, Cost Effective Nanoparticle Processes
RENO, NV. – September 4, 2002 – Altair Nanotechnologies (NASDAQ:ALTI) announced today that it was awarded its second patent “Processing Aqueous Chloride Solution to Ultrafine Titanium Dioxide” by the US Patent Office. Patent number 6,440,383 was issued on August 27, 2002.
The new patent describes the fundamental technology for producing Altair’s nanomaterials and is the platform for many of the subsequent patent applications that have been filed for the manufacturing of specific nanomaterials including new materials for pharmaceutical applications. According to extensive market research by Business Communications Company, Inc., the total world market for nanoparticles is projected to rise at a 12.8 percent average annual growth rate, exceeding $900 million in 2005. The new patent follows a recently awarded patent covering the environmentally friendly process for TiO2 pigment production, an $8 billion industry.
Altair believes products made with its new process have the advantage of being superior due to the narrow particle size distribution, the control of physical and chemical properties, and the low cost of processing the materials. It is important to note that the environmental features so important in the company’s patented base process for titanium dioxide pigment are retained in the new process for inexpensively manufacturing commercial quantities of its nanomaterials.
“To date Altair has filed eight additional patents that have been developed on the foundation provided by our two recently issued patents,” commented Altair President Dr. Rudi E. Moerck. “We are continuing to develop additional products and applications that will allow us to work with licensees and strategic partners for accelerating the market entry of our products and technologies. We are currently seeking evaluation license partners for our new phosphate-lowering drug and commercial arrangements with pigment manufacturers. Titanium pigment samples from the Altair process will be available to select pigment producers in the next two weeks and samples of our new phosphate binding drug API are available immediately.”
“An article discussing our new pharmaceutical for the treatment of elevated phosphate levels in kidney dialysis patents appears in the August issue, Volume 5, Number 7, of Nanoparticle News,” said Dr. Moerck. “In preliminary testing, our ceramic micro-structured material outperformed existing drugs in removing phosphates.”
Altair is focusing considerable effort on the continued development of intellectual property related to new pharmaceutical products for the treatment of elevated phosphate levels in kidney dialysis patients. This concentration has led to significant interest by a number of large pharmaceutical companies. The company’s strategy is to grant evaluation licenses to those companies with the ability to further develop the drug and bring product to market. Dr. Moerck noted, “This ongoing development is supported through small equity fundings as we believe it would be detrimental to the company and its shareholders to raise significant capital in today’s depressed public markets.”
ALTAIR NANOTECHNOLOGIES, INC.
Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterials and technology worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation. For additional information on Altair’s nanoparticle materials, visit www.altairnano.com.
Forward-Looking Statements
This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the Company’s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the possibilities that the Company may be unable to attract additional customers, funded research opportunities, product development opportunities or ventures through its sales and branding campaign, that the Company may never earn sufficient revenues to be profitable and that the Company’s nanoparticle products may not be integrated into any major market groups and products, in addition to other risks identified in the Company’s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The Company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in Company expectations or results or any change in events.
Wie ich hörte braucht die Firma dringend Geld um weiterarbeiten zu können. Habe aber leider nichts Schriftliches nur vom Börsenstammtisch.
Aber ein Secondary bei diesem Kurs finde ich echt hart. Warum ist diese NASDQ Firma eigentlich so schwach auf der Brust. Wenn die so weitermachen landen die sofort an der OTC. Na schau´n mer mal was passiert. Aber ist schon sehr seltsam, daß sich die Unternehmen nie selbst sanieren können. Ich kann mich noch gut an die Nanotec Firma St. Mems erinnern, wo unter anderem sogar das Frauenhofer Institut Partner war und man auf den großen Einstieg der Deutschen Bank spekulierte. Und jetzt stehen die armen Aktionäre da, keine News, kein Management mehr und die Kohle sehr wahrscheinlich wech! Dabei war das Unternehmen schon interkontinental tätig. Vielleicht auch nur ein Ablenkungsmanöver :angry: um so blöde Investoren wie mich zu ködern. Auf den Börsengang warten wir immer noch, Schöne Schei..., aber was soll´s das Marktsegment ist höchst interessant und ich traue auch ALTI eine Menge zu. Aber seltsamer Weise gibt es in den Staaten keine Kohle mehr für die Bude- warum? Und warum suchen die Kohle hier in Deutschland, wo doch überhaupt keine Geschäftsaktivitäten hier stattfinden, außer vielleicht das der Eigner einen Deutschen Schäferhund besitzt ( Kleiner Witz am Rande). Wir werden es erleben wie es ausgeht.
Auch bei 70 cts eine Kapitalerhöhung, da muß man doch vorher ein wenig Kurspflege betreiben um geschickt mehr Kapital einzusammeln. Irgendetwas passt da nicht, oder es brennt lichterloh. Ich beobachte das! :cool:
Grüße McLeod
ALTAIR NANOTECHNOLOGIES NAMES ITS NEW PHARMACEUTICAL FOR KIDNEY DIALYSIS PATIENTS RENAZORB™
Renazorb’s™ Successful Laboratory Tests For Phosphate Removal Attract Attention of Major Pharmaceutical Companies
RENO, NV. – September 10, 2002 – Altair Nanotechnologies (NASDAQ:ALTI) announced today that it has named its new pharmaceutical for the removal of phosphate ions in kidney dialysis patients Renazorb™. Renazorb™ has been developed specifically for the treatment of elevated phosphate levels in patients with end stage renal disease undergoing kidney dialysis. The new pharmaceutical is a lanthanum-based ceramic micro-structured material that effectively binds phosphate and is designed to remove these ions in the gastrointestinal tract without absorption of the drug into the bloodstream. Altair has already filed patent applications for Renazorb™.
“When we compared the phosphate binding of Renazorb™ with commercially available lanthanum carbonate tetra hydrate in the laboratory using simulated human stomach fluid containing phosphate, Renazorb’s™ reaction rates for binding the phosphate were approximately twice those displayed by the benchmark material,” said Altair President Dr. Rudi E. Moerck. “In addition to the rapid removal of phosphate, the amount of Renazorb™ required to remove phosphate from the gastrointestinal tract was about 2.5 times less than the benchmark material. This finding is significant as it could reduce the amount of the drug used in dosing and may dramatically increase patient compliance.” Dr. Moerck went on to note that Renazorb™, a highly insoluble drug, showed undetectable amounts of free lanthanum in simulated stomach fluid.
Altair has executed four confidentiality agreements with major pharmaceutical companies and is currently negotiating a fifth agreement. Three pharmaceutical companies have shown interest in the use of Renazorb™ in a filtration device that could be used during kidney dialysis to remove phosphate directly from blood serum. Two additional major international pharmaceutical companies have shown a general interest in using Altair’s nanomaterials and patented porous nanostructures for drug delivery and pharmaceutical sustained release applications. In many cases new drug delivery systems allow pharmaceutical companies to extend patent protection on existing drugs.
According to Dr. Moerck, Altair’s strategy is to provide laboratory and performance data to a number of pharmaceutical companies and to grant evaluation licenses to those companies that express interest in developing Renazorb™ as a drug. The company will also consider exclusive evaluation licenses and exclusive full drug licenses.
ALTAIR NANOTECHNOLOGIES, INC.
Nanotechnology is rapidly emerging as a unique industry sector. Altair Nanotechnologies is positioning itself through product innovation within this emerging industry to become a leading supplier of nanomaterials and technology worldwide. Altair owns a proprietary technology for making nanocrystalline materials of unique quality both economically and in large quantities. The company is currently developing special nanomaterials with potential applications in pharmaceuticals, fuel cells, solar cells, advanced energy storage devices, thermal spray coatings, catalysts, cosmetics, paints and environmental remediation. For additional information on Altair’s nanoparticle materials, visit www.altairnano.com.
Forward-Looking Statements
This release may contain forward-looking statements as well as historical information. Forward-looking statements, which are included in accordance with the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, may involve risks, uncertainties and other factors that may cause the Company’s actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. These risks and uncertainties include, without limitation, the possibilities that the Company may be unable to attract additional customers, funded research opportunities, product development opportunities or ventures through its sales and branding campaign, that the Company may never earn sufficient revenues to be profitable and that the Company’s nanoparticle products may not be integrated into any major market groups and products, in addition to other risks identified in the Company’s most recent Annual Report on Form 10-K, as filed with the SEC. Such forward-looking statements speak only as of the date of this release. The Company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in Company expectations or results or any change in events.
Bei Altair Nanotechnologies bin ich sehr optimistisch. Dafür gibt es einen einfachen Grund.
Es wird eine Zeit kommen, in der allein die Silbe „nano“ für enorme Kurssteigerungen sorgen wird. Erinnern wir uns nur an die dot.coms.
Davon abgesehen ist die Firma auf vielen Gebieten tätig, Verkauf von Nanopartikeln und bei der Entwicklung neuer Brennstoffzellen. Einige Patente in bezug auf die Gewinnung dieser winzigen Partikel sorgen ebenfalls für Phantasie.
Sollte es dem Unternehmen gelingen, zukünftig mehr Einnahmen zu generieren, könnte dieses ein durchaus lukratives Investment werden.
Long
Dawnrazor
13.09.2002, 17:01
Es wird eine Zeit kommen, in der allein die Silbe „nano“ für enorme Kurssteigerungen sorgen wird.
Diese Zeit gab's doch schon... :confused:
Erinnern wir uns nur an die dot.coms.
Genau so sehen die Charts der Nanotech-Aktien nämlich aus: :rolleyes:
http://cchart.yimg.com/z?s=nano&a=v&p=s&t=5y&l=off&z=m&q=c
http://cchart.yimg.com/z?s=ngen&a=v&p=s&t=5y&l=off&z=m&q=c
http://cchart.yimg.com/z?s=nanx&a=v&p=s&t=5y&l=off&z=m&q=c
In einer Baisse die nunmehr fast drei Jahre dauert, sehen grundsätzlich alle Charts ähnlich aus.
Für den hartgesottenen Börsianer genau der richtige Zeitpunkt in zukünftige Wachstumsbranchen zu investieren. Eine davon wird die Nanotechnologie sein. Nanometrix ist übrigens nicht dazu zu rechnen, Nanogen als Biostock nur bedingt, und Nanophase hängt untrennbar von den Aufträgen von BASF ab und ist damit in Forschung und Entwicklung massiv eingeschränkt.
Herausragende Positionen besitzt Big Blue und ziemlich am Ende der Fahnenstange auch Altair. Beide sind als Basis eines Nanotech-Investments hervorragend geeignet.
Gruß
Long
Dawnrazor
14.09.2002, 14:09
Nanometrix ist übrigens nicht dazu zu rechnen, Nanogen als Biostock nur bedingt, und Nanophase hängt untrennbar von den Aufträgen von BASF ab und ist damit in Forschung und Entwicklung massiv eingeschränkt.
Um mal aus "Vom Winde verweht" zu zitieren (http://www.click-smilie.de/sammlung/schilder/smilieschilder/Huhu.gif Huhu, TheKing!):
"Offen gesagt ist mir das völlig gleichgültig." ("Frankly, my dear, I don't give a damn.")
Denn ich habe nur mal drei Chart herausgepickt, die Deinem Kriterium entsprechen:
Es wird eine Zeit kommen, in der allein die Silbe „nano“ für enorme Kurssteigerungen sorgen wird.
the mind
14.09.2002, 19:02
:doll:
Nanotec Firmen haben tatsächlich eine riesen Zukunft. Die Frage ist nur , welche Firmen sich durchsetzen werden und das ist gar nicht so einfach abzuschätzen. Anscheinend verbraucht die Forschung und die Umsetzung sehr viel Geld und so wird sich wohl schnell die Spreu vom Weizen trennen. ALTI ist da wohl eher ein kleines Unternehmen und ich sehe in diesem Falle eher Probleme auf das Unternehmen zukommen, wenn da kein Namhaftes Unternehmen miteinsteigt. Der Trend in dieser Branche wird sicherlich bald wieder nach oben zeigen, sodaß man ein Auge auf diese Unternehmen haben sollte.
McLeod
Hallo McLeod,
bei einer so jungen Branche wie der Nanotechnologie ist es zwingend notwendig, so breit wie möglich zu diversifizieren. Wie ich schon sagte, bevorzuge ich dabei grundsätzlich den Marktführer, hier IBM, und einige kleine, ja sogar winzige Unternehmen, wie Altair. Bei ALTI
kann ich Ansätze erkennen, die eine Investition rechtfertigen. Sie arbeiten im lukrativen Segment der Nanopartikel und besitzen dort einige Patente, und sind anders als z.B. Nanophase, völlig unabhängig. Außerdem forschen sie mit dem MIT an der Entwicklung der nächsten Generation von Brennstoffzellen. Darüber hinaus arbeitet Altair mit europäischen Wissenschaftlern auf dem Gebiet der Solarenergie und entwickelt ferner hitzebeständige Anstriche u. a. für die Navy.
All dieses und die lange Tradition des Unternehmens (1973 gegründet 1994 auf „Nano“ fixiert)
lassen ein Engagement aussichtsreich erscheinen.
Nach fast dreijähriger Baisse um so mehr.
Schönen Gruß,
Long
23.04.2004
Altair Nanotechnologies hochspekulativ
Prior Börse
Nach Ansicht der Experten der "Prior Börse" ist die Aktie von Altair Nanotechnologies (ISIN CA0213731056/ WKN 902675) ein hochspekulatives Investment.
Die Nanotechwelle schwappe nach Deutschland. Altair Nanotechnologies tüftele an einem Verfahren, um Titan günstiger produzieren zu können. Des Weiteren beschäftige sich die Gesellschaft mit der Herstellung von weißen Pigmenten. Außerdem erforsche die Nasdaq-Firma ein Medikament zur Absenkung erhöhter Phosphatwerte im Magen-Darm-Trakt.
Sicherlich sei Altair ein Forschungsunternehmen. In diesem Jahr dürfte lediglich eine Million Dollar Umsatz erzielt werden. Im vergangenen Jahr habe der Verlust 6 Mio. USD betragen. Der Turnaround sei nicht absehbar. Es würden bahnbrechende Lizenzabkommen fehlen. Der Barbestand sei mit 11,5 Mio. USD zwar komfortabel. Allerdings würden in der 129 Mio. USD Börsenbewertung reichlich Vorschusslorbeeren stecken.
Anleger, die an Nanotechnologie interessiert sind, können sich nach Meinung der Experten der "Prior Börse" ein paar Aktien von Altair Nanotechnologies ins Depot legen. Die Börsenkenner würden auf den hochspekulativen Charakter dieses Investments hinweisen.
Major Shareholder of Altair Nanotechnologies, Inc. Calls for Termination of Mining ...
23.04.2004
02:59
RENO, Nevada, April 22 /PRNewswire/ -- Lou Schnur, a major shareholder of Altair Nanotechnologies, Inc. , today called on Altair''s directors to instruct management to immediately sell or mothball its chronically unprofitable mining operations and focus exclusively on nanotechnology opportunities.
Altair is a company engaged in developing nanomaterials, titanium dioxide pigment technology, and materials science focused on nanostructures.
Schnur has filed a Schedule 13D with the Securities and Exchange Commission outlining generally the views expressed in this release.
Schnur, a CPA, longstanding Altair investor, and 9.9% beneficial owner of Altair''s outstanding stock and warrants, said Altair''s mining operations appear to have generated economic losses of $30 million from 1973 through 2003. Also, Schnur criticized the proposed action by Altair to spin off the mining operations as a further distraction and waste of corporate assets.
Schnur said, "The continuing costs to maintain mining personnel and operations, together with attendant legal, accounting and shareholder solicitation costs necessary to implement a spin-off, are economic losers. The assets are carried on Altair''s books at zero value, have never produced significant revenues, much less profits, and they should either be sold or mothballed quickly."
Schnur said he supports Altair''s December 19, 2003 announcement of a restructuring program whereby the two development stage mining projects would be terminated, so that Altair could focus 100% of its personnel and other resources on its most promising business enterprise, the Reno, Nevada Materials/Nanotechnology Division.
But he says that a March 16, 2004 Altair announcement is contradictory to the stated goals of the restructuring in that there would be a continued focus on mining activities. That release states in part:
"Altair plans to distribute (or spin off) to its shareholders the capital stock of a subsidiary holding the assets of the current Mineral Recovery Systems (MRS) division. Altair intends to solicit shareholder approval for the spin off and complete the filings necessary to make MRS a reporting company. MRS will hold the rights to the exploration-stage mineral deposit in Camden, Tennessee, the ownership of the Altair centrifugal jig and related intellectual property for agglomeration of titanium dioxide.
Dr. William P. Long will resign his position as Chief Executive Officer and member of Altair''s board of directors as of May 1, 2004. Dr. Long is expected to serve as the President of MRS ... "
Altair''s SEC report on Form 10-K for the fiscal year ended December 31, 2003 disclosed aggregate losses of $17.6 million, by subsidiaries, relating to the centrifugal jig and the Tennessee mining projects. Schnur said he believes the reporting of "subsidiaries losses," as being indicative of total mining losses, is understated and misleading.
Schnur also said, "After reviewing the financial statements in the SEC filings, and as an active shareholder (and a CPA, formerly employed by Price Waterhouse & Co.), it is my opinion that a more realistic economic assessment of Altair''s $46 million loss, from inception in 1973 to December 31, 2003 (30 years) is:
Mining development projects division - 30 years $30 million Reno materials/nanotech division - 3 years $16 million Altair''s total loss from 1973 - December 31, 2003 $46 million."
Schnur said he believes shareholder value will be maximized by the immediate termination of mining personnel and of all controllable mining expenditures, and the disposal of the mining projects by public auction, prior to December 31, 2004. The auction should be advertised in "The Northern Miner," with project descriptions mailed to potential interested companies and investors. Altair alumni, suppliers, business prospects and others would have equal opportunity in a public auction.
A definitive, comprehensive disposal of the mining projects will bring closure to a long-term, failed business venture (and to Altair''s team of mining directors and managers), maximize Altair''s chances for commercial success, and hopefully set the stage for a long overdue return on investments made by Altair shareholders, Schnur said.
To explain his reasoning in estimating Altair''s mining losses, Schnur noted that Altair''s only business until November 1999 was mining, and that it did not have significant nanotech expenses until 2001. In November 1999, Altair purchased certain technology assets from BHP Minerals International, Inc. (BHP), including, for a one-year period, the services of certain BHP personnel involved in the development of the acquired technology. Accordingly, Altair did not incur salary expenses for the technology operation from November 15, 1999 through November 15, 2000, since these expenses ($1,535,985) were part of the total $9,625,560 purchase price Altair paid BHP.
Altair reported in its Form 10-K for 2000 that it had accumulated deficits during the development stage of $21,606,378, virtually all of which, Schnur says, was attributable to mining.
As to years following 2000, Altair reported in its annual report for 2003 that "management views the company as being three business segments: Nanomaterials and Titanium Dioxide Pigment Technology, Tennessee Mineral Property, and the Jig." The following "Loss from Operations" was also reported:
Unallocated Tennessee Jig Mining Total 2003 $2,778,885 $155,709 $27,729 $183,438 2002 1,871,953 598,977 2,929,010 3,527,987 2001 2,006,198 930,777 300,913 1,231,690 TOTALS $6,657,036(B) $1,685,463 $3,257,652 $4,943,115(A) Mining Deficits from April 9, 1973 through December 31, 2000 $21,606,378 Mining Deficits from 2001 through 2003 (A) 4,943,115 Estimated allocation of one-half of the $6,657,036 "unallocated expense" to the Tennessee Mineral Property and the Jig. (B) 3,328,518 Actual Mining Loss from inception through 2003 $29,878,011
Together with the Reno building and cash realized from the exercise of warrants (as a result of investor enthusiasm for Altair''s Nanotech Division), the nanotech assets are the only significant assets on the December 31, 2003 Balance Sheet. The mining projects were written off. Schnur said he believes that Altair should have established a "Reserve for Loss on Disposal of Mining Projects" at December 31, 2003.
Schnur noted that the President''s Message in Altair''s 2000 annual report stated " ... the Camden titanium deposit, with its tremendous resource value, remains the financial underpinning of the company. We have continued with our deliberate development of the property as the world capacity for extraction of titanium mineral resources has continued to decline."
"After $30 million of losses, and diminished odds of obtaining necessary mining permits, as well as a viable operating partner," Schnur said, "it is time to cut the mining loss and give 100% to Materials/Nanotech. In my opinion, the losses actually attributable to the mining operations are greater than the amounts that have been reported."
All of Altair''s directors and senior management were mining personnel until Rudi Moerck was hired in March 2002, a move Schnur supports. The mining division had offices, in Cody, Wyoming and Reno, Nevada (complete with jig). The Tennessee pilot plant and tailings pond were constructed and operated in 2000-2001. The BHP purchase was mostly paid from $8,904,029 received for common stock sold in 2000 (at an average price of $2.36). Altair''s proceeds from the Doral 18 LLC loan provided very little net cash to Altair; the loan carried a very high interest rate; and the loan resulted in significant dilution since warrants were issued as part of the loan, and significant repayments were made in common stock, at historically low prices.
Schnur said that four months after the December 2003 restructuring announcement, Altair continues the mining payroll, lease payments to Tennessee landowners, engineering support for the jig in Africa, maintenance and environmental exposure for the pilot plant and tailings pond, an office in Cody, etc. Moreover, the spin-off might generate another $500,000 of expenses to be borne by Altair. Shareholders should demand that Altair directors order the immediate termination of this wasteful spending.
This release is not intended, and does not constitute a solicitation of proxies by Schnur or any other person or group. Instead, in the interest of open shareholder communications, and in accordance with applicable SEC rules, it is intended to promote open communication among all shareholders concerning their views on the policies and decisions of Altair''s management.
Lou Schnur
© PR Newswire
the mind
26.04.2004, 23:07
ALTI (3,0$) sieht nach dem heutigen tag gar nicht mal schlecht aus, für signifikantes up-potential muss aber bald die 3,5$-hürde genommen werden.
http://chart.bigcharts.com/bc3/intchart/frames/chart.asp?symb=alti&compidx=aaaaa%3A0&ma=1&maval=20%2C50%2C100%2C200&uf=8&lf=268435456&lf2=32&lf3=1024&type=4&size=2&state=11&sid=1198546&style=320&time=7&freq=1&comp=NO%5FSYMBOL%5FCHOSEN&nosettings=1&rand=539&mocktick=1
Huhu,
nach der heutigen Meldung bin ich zuversichtlich, dass wir die 3,5 $ bald knacken werden. Es gibt ja Stimmen, die behaupten, Altair sei hoch bewertet, aber es ist ein Wert mit Phantasie und Charme. Ich bin schon seit Längerem mit einer kleinen Position drin und habe ein gutes Gefühl, wenngleich man in dieser Branche - und speziell mit diesem Unternehmen - große Schwierigkeiten in der Beurteilung von sogenannten Fakten hat und vorläufig auch noch haben dürfte. Bislang sehe ich es so wie viele anderen hier wohl auch: Altair ist ein "Zockerwert" mit Pfiff.
Grüßle
glitsch :dunce:
22.06.2004
Altair Nanotechnologies interessant
Nasd@q Inside
Die Experten von "Nasd@q Inside" halten die Aktie von Altair Nanotechnologies (ISIN CA0213731056/ WKN 902675) für charttechnisch interessant.
Der Konzern sei in erster Linie durch die Produktion von nanokristallinen Stoffen bekannt. Diese könnten sowohl in der Pharmazeutik als auch in Batterien, Solarzellen und Kosmetika eingesetzt werden. Jedoch dominiere bei vielen Produkten noch das Entwicklungsstadium, so dass der Umsatz vernachlässigbar sei. Erwähnenswert sei zudem, dass die Firma noch in den roten Zahlen stehe.
Demnach sei im ersten Quartal ein Verlust von 0,04 Dollar je Aktie erzielt worden, allerdings mit zunehmend positiver Tendenz. Die Tatsache, dass Altair Nanotechnologies kaum verschuldet sei und die Anwendungsgebiete der Produkte theoretisch sehr breit gefächert seien, lasse das Unternehmen vorteilhaft in Erscheinung treten.
Die Aktie habe seit April vergangenen Jahres in der Spitze fast 1.400% zugelegt. Inzwischen habe das Papier von diesem Niveau wiederum 50% korrigiert. Diese mache evtl. ein baldiges Ende der Korrektur möglich. Vorausgesetzt die Erholungstendenz setze hier ein, könnte spekulativ mitgespielt werden. Doch dies sei nur Investoren zu empfehlen, die sich des Risikos bewusst seien.
Die Altair Nanotechnologies-Aktie erachten die Experten von "Nasd@q Inside" als charttechnisch interessant.
the mind
22.06.2004, 18:27
Auge, hab den thread mal wieder gemerged, du willst doch nicht etwa die mods ärgern :D
Sorry, wollte besonders schnell sein und habe dann gepfuscht :rolleyes: :bang:
shortbull
22.06.2004, 20:41
ALTI...
http://chart.bigcharts.com/bc3/intchart/frames/chart.asp?symb=alti&compidx=aaaaa%3A0&ma=3&maval=9&uf=8&lf=32&lf2=4&lf3=0&type=4&size=2&state=8&sid=1198546&style=320&time=4&freq=1&comp=NO%5FSYMBOL%5FCHOSEN&nosettings=1&rand=9829&mocktick=1
....charttechnisch ein kauf...aber nur für zocker :rolleyes: :D
Trüffelschwein
10.02.2005, 23:05
Altair Nanotechnologies Achieves Breakthrough in Battery Materials
THURSDAY, FEBRUARY 10, 2005 9:45 AM
- Market Wire
RENO, NV, Feb. 10, 2005 (MARKET WIRE via COMTEX) -- Altair Nanotechnologies, Inc. (ALTI) announced today that it has achieved a breakthrough in Lithium Ion battery electrode materials, which will enable a new generation of rechargeable battery to be introduced into the marketplace, as well as create new markets for rechargeable batteries. These new materials allow rechargeable batteries to be manufactured that have three times the power of existing Lithium Ion batteries at the same price and with recharge times measured in a few minutes rather than hours.
The technical achievements are being praised by the battery community as truly remarkable and will likely enable a new generation of rechargeable battery to be produced. Altair has confidentiality agreements in place with some of the world's leading battery development companies to evaluate and commercialize these battery electrode materials.
Altair's research and development efforts were allowed two new patents (announced on January 7th and 14th, 2005) and a National Science Foundation grant was successfully completed in January, 2005, by Altair. New markets for fast charging batteries will include the handheld power tools market increasing the productivity of, for example, construction workers while lowering their overhead costs. Other markets include hybrid electric vehicles, portable electronics and medical surgery tools -- solving the problem of electrical wires all over the operating room floor.
Endorsements for Altair's work in this area have come from many quarters. Two eminent experts in battery technology, Dr. K. M. Abraham and Dr. Vassilis G. Keramidas, have expressed strong support for Altair's work
"The nanomaterials Altair is developing are the next generation of electrode materials for lithium-ion batteries and Altair's research and product development is laying the ground work for a new generation of ultra high power lithium ion batteries," commented Dr. K. M. Abraham. "A key requirement to the above applications is the ability to recharge the battery very quickly, for example in a few minutes. Current Li Ion batteries are incapable of such quick charge times because of the chemistry of the anode materials. Altair has found a solution to this with their nano-sized lithium titanium oxide."
"Altair's nanomaterials, which have a virtually zero strain crystal lattice, eliminate the main cause for battery electrode material fatigue, which limits rechargeable battery life, increasing the number of recharge and discharge cycles from a few hundred to many thousand cycles," said Dr. Vassilis G. Keramidas. "I find Altair's development strategy and proposed research direction sound and a necessary step in establishing the Li-Ion electrochemistry as a viable contender for large battery applications."
"Our research in battery electrode materials is a further indication of how Altair's scientists are able to apply their nanomaterials science knowledge to solving real world needs," commented Altair CEO Dr. Alan J. Gotcher. "Many of the technology and product development initiatives that we have been working on for the last few years are now coming to the commercialization stage. Each step is another validation of our business strategy and product technology platform. Altair's nanomaterial based, micro porous electrode technology has performance and stability advantages that appear to be unmatched when compared to the best commercialized technology in the market today."
Dr. K. M. Abraham
Dr. Abraham, the principal of E-KEM Sciences, has over 28 years of experience in lithium battery research and development. He has made pioneering contributions to the development of the rechargeable battery industry. Dr. Abraham has authored and co-authored over 150 publications and 16 US patents in battery technology. He received his Ph. D. from Tufts University and conducted post-doctoral research at Vanderbilt University and MIT. In 2000 he was elected a Fellow of the Electrochemical Society. Dr Abraham is on Altair's Scientific Advisory Board.
Dr. Vassilis G. Keramidas
Dr. Keramidas, Managing Director of Keramidas International, provides management consulting to major corporations on the formulation and execution of their research and development. Prior to founding Keramidas International, he was Vice President of Applied Research at Telcordia Technologies (formerly Bellcore). His division at Telcordia made seminal contributions in the fields of photonic and electronic materials. The Bellcore research on energy storage ushered in the polymer battery Li-Ion technology with the invention of the Bellcore Plastic Li-Ion (PLiON) technology. Dr. Keramidas sits on the Board of two battery companies.
ALTAIR NANOTECHNOLOGIES INC.
Altair Nanotechnologies, through product innovation, is a leading supplier of advanced ceramic nanomaterial technology worldwide. Altair Nanotechnologies has assembled a unique team of material scientists who, coupled with collaborative ventures with industry partners and leading academic centers, has pioneered an impressive array of intellectual property and product achievements.
Altair Nanotechnologies has developed robust proprietary technology platforms for manufacturing a variety of crystalline and non-crystalline nanomaterials of unique structure, performance, quality and cost. The company has a scalable manufacturing capability to meet emerging nanomaterials demands, with capacity today to produce hundreds of tons of nanomaterials.
The company is organized into two divisions: Life Sciences and Performance Materials. The Life Sciences Division is pursuing market applications in pharmaceuticals, drug delivery, dental materials, cosmetics and other medical markets. The Performance Materials Division is pursuing market applications in Advanced Materials for paints and coatings; titanium metal manufacturing, catalysts and water treatment; and alternative energy. For additional information on Altair and its nano-materials, visit www.altairnano.com
Altairnano(TM), Altair Nanotechnologies, Inc.(R), Altair Nanomaterials(TM), TiNano(R), RenaZorb(TM), NanoCheck(TM), TiNano Spheres(TM) and the Hydrochloride Pigment Process(TM) are trademarks or registered trademarks of Altair Nanotechnologies, Inc.
http://bigcharts.marketwatch.com/charts/big.chart?symb=alti&compidx=aaaaa%3A0&ma=1&maval=20&uf=8&lf=1&lf2=8&lf3=32&type=4&size=2&state=11&sid=1198546&style=320&time=7&freq=1&comp=NO%5FSYMBOL%5FCHOSEN&nosettings=1&rand=3019&mocktick=1
the mind
10.02.2005, 23:12
solchen batterien wären natürlich krass :eek: - was dazu unser akku-fritze :D Digedag sagen würde? :chin:
:nounder: :nounder: :nounder:
wenn mir das jetzt noch einer auf deutsch erzählen könnte
:wonder: :chin: :bang:
digedag digedi digedo. digewo??? :D
hab das mal bei systran reingeschmissen, die übersetzung war verständlich.
dreifache energiedichte und sehr kurze ladezeit, was soll ich dazu sagen, ist doch super. frage wäre, ob die die energie auch so schnell wieder abgeben können, das ist nämlich bisher auch ein mangel, deshalb werden sie in akkuschraubern nicht verbaut un nimh ist nur dreck. ladezyklen sollen auch höher sein, ist auch super, wenn sich auch die gesamtlebensdauer erhöht. im moment liegen die bei liion bei ca. 2 jahre.
Ist das seriös?:chin:
Ich erinnere nur an die Neuerfindung des Turboladers von Turbodyne :eek:
schwere frage auge, manchmal reicht ein funke, um was zu bewegen.
böttcher hat auch zufällig das weiße gold erfunden.
in der regel fallen aber kleinere schritte an, denke, das sind ein paar zu viele verbesserungen. es wird schon lange an der li-ion technologie gearbeitet und die marktführer wie sanyo und panasonic sind doch auch nicht dumm.
ist dann noch die frage, wann das marktreif wird, zumal in 2 jahren ni-cd verbannt werden soll und es zu den zellen im akkuschrauberbereich im moment keine wirkliche alternative gibt.
[KERN]Codex
13.02.2005, 21:33
Altair Nanotechnologies Inc.(WKN: 902 675),
ist ein Unternehmen der Nanotechnologie. Es werden Nanomaterialien und Beschichtungen hergestellt, Nanoröhrchen her in denen sich Wasserstoff speichern lässt (Brennstoffzellentanks). Auf der Web-Site des Unternehmens wurde gestern eine Pressemitteilung veröffentlicht. Das Unternehmen, so schreibt es, habe einen Durchbruch bei Materialien für Lithium Ion Batterien erzielt, der eine neue Generation von wiederaufladbaren Batterien ermöglicht, die in den Markt eingeführt werden können. Die neuen Materalien erlauben wiederaufladbare Batterien zu produzieren, die drei mal die Kraft von existierenden Lithium Ion Batterien hätten und dies zum gleichen Preis, so das Unternehmen. Nach 14 Preisfeststellungen konnten die Aktien der Firma ein Plus von über 61 Prozent erzielen.
Heißt das die Gespräche über zukünftige Verträge mit Sanyo und co. laufen bereits und die neuen AKKUS stehen kurz vor der Markteinführung, oder fließt der CASH erst nächstes Jahr?! :rolleyes:
[KERN]Codex
15.02.2005, 03:08
Am Donnerstag gegen 1100 a.m. gibt es einen Conference Call, ich erwarte heri einen ausführlichen Ausblick auf das Jahr 2005 :tup:
Butzel66
15.02.2005, 16:49
Das erklärt die "Gewinnmitnahmen" etwas......wobei ich eher "Flucht aus der Aktie" sagen würde!
--------------------------------------------------------------------------------------------------
Altair Nanotechnologies, Inc. Announces Shelf Registration Closing
RENO, NV -- (MARKET WIRE) -- 02/15/05 -- Altair Nanotechnologies, Inc. (NASDAQ: ALTI (javascript:_NewsTicker('ALTI'))) announced today that it has entered into definitive agreements with respect to the sale of five million shares of its common stock to institutional investors at a price of $4.05 per share, for gross proceeds of approximately $20,250,000. Following closing of the financing, which is expected to occur today, Altair expects to receive approximately $19,237,500 after deducting all fees and expenses. With the completion of the placement, Altair will have 56,794,724 shares of common stock issued and outstanding. Maxim Group LLC is acting as placement agent for the transaction. As consideration, Maxim Group LLC is entitled to receive a cash fee equal to 5% of the gross proceeds from the offering and a warrant to purchase 250,000 shares of common stock at an exercise price of $5.265 during a four year term, and is subject to one demand registration right and unlimited incidental registration rights.
The proceeds will be used for general corporate purposes, including, but not limited to, working capital, capital expenditures, research and development activities and the acquisition of other technologies.
was steht da drin, butzel :rolleyes:
die Kursexplosion war wohl nur ein Strohfeuer....
....sollte man meiner Meinung nach wieder vergessen......
lag ich wohl nicht so ujnrecht mit meinen gedanken? :rolleyes: :eek:
Butzel66
16.02.2005, 11:22
was steht da drin, butzel :rolleyes:
-----------------------------------------------------------------------------------------------
Hier das Wichtigste:
Altair hat bekannt gegeben, daß man 5 Mio. Aktien zu einem Preis von USD 4,05
(also deutlich unter der zu diesem Zeitpunkt aktuellen Börsennotierung) an institutionelle Investoren verkauft habe, um "schnell mal zusätzliche ca. 20 Mio $
für Investitionen zur Verfügung zu haben!
Von einer Sperrfrist - wie es hierzulande üblich gewesen wäre, ist in der Mitteilung keine Rede!
D.h. Die "Investoren" hätten (und haben dem Kursverlauf nach wohl auch) diese Aktien an der Börse gleich am nächsten Tag wieder zum gültigen / aktuellen
Börsenkurs verkaufen können - und damit einen dicken "Batzen Dollars" verdient!!
Das ist schlichtweg eine Sauerei gegenüber den "normalen Aktionären", die diese "Spielchen" mit ihrem Geld bezahlen müssen (Kursverfall)
Ähnliche "Aktivitäten" - verpackt in der Bezeichnung "Private Placements"
gab es vor kurzem bei der hochgelobten chinesschen Firma SINOVAC (SVA)
= Kürzel an der AMEX, oder WKN 789125 in Deutschland!!
Schau dir auch dort die Kursentwicklung an! (Ähnliches "Strickmuster"!!):mad:
Altair Nanotechnologies hat 5 Mio. junge Aktien an institutionelle Investoren ausgegeben. Die Papiere wurden zum Emissionspreis von 4,05 Dollar platziert. Weitere 250.000 Aktien sind als Greenshoe platzierbar. Mit den Geldern soll der Kapitalbedarf des Unternehmens gedeckt und evtl. Akquisitionen vorgenommen werden.
Schreit nach Abzockerei... :hmpf:
[KERN]Codex
18.02.2005, 00:54
@butzel66
ich denke das ALTI Management hat auch nicht damit gerechnet, dass die Aktie in so kurzer Zeit so viel zulegt, deswegen war die Kapitalerhöhung für die breite Masse im Endeffekt zu niedrig angesetzt..
Wäre der Kurs nur auf 3,75$ gestiegen hätte es eine ganz andere Resonanz gegeben.
Ich denke viele große Firmen haben Interesse an ALTIs Technologie(n) bekundet und es gibt in Zukunft bestimmt noch mehr Kapitalerhöhungen, was denkst du/ihr?
Dieser Satz ist mir eben nochmal besonders ins Auge gesprungen:
"Our research in battery electrode materials is a further indication of how Altair's scientists are able to apply their nanomaterials science knowledge to solving real world needs," commented Altair CEO Dr. Alan J. Gotcher. "Many of the technology and product development initiatives that we have been working on for the last few years are now coming to the commercialization stage. Each step is another validation of our business strategy and product technology platform. Altair's nanomaterial based, micro porous electrode technology has performance and stability advantages that appear to be unmatched when compared to the best commercialized technology in the market today."
..das heißt doch, dass dies erst der Anfang war und es noch viel mehr Einsatzbereiche mit ALTI Technik gibt, zum Beispiel Solarzellen usw.
Vielleicht warten in diesem Jahr noch einige spannende Meldungen auf uns (!)
gruß codex
p.s.Glaubt ihr der Kurs driftet deutlich unter die 4$ Marke falls es in naher Zukunft keine News geben sollte? (Ich nicht..)
Trüffelschwein
18.02.2005, 01:17
Codex']p.s.Glaubt ihr der Kurs driftet deutlich unter die 4$ Marke falls es in naher Zukunft keine News geben sollte? (Ich nicht..)Ich auch nicht. Bis jetzt ist der Chartverlauf absolut normal für so eine Kiste.
Wenn das Volumen wieder anzieht und die Tagestiefs ansteigen (letzteres war eigentlich gestern schon der Fall), kann man m.E. einen Zock mit SL bei 3.95 USD wagen.
Eine Variante wäre, heute einzusteigen und einen möglichen Gap-up am Montag abzuverkaufen.
Ist natürlich hochspekulativ und nichts für schwache Nerven oder schmale Geldbeutel.
Butzel66
18.02.2005, 09:00
Codex']@butzel66
ich denke das ALTI Management hat auch nicht damit gerechnet, dass die Aktie in so kurzer Zeit so viel zulegt, deswegen war die Kapitalerhöhung für die breite Masse im Endeffekt zu niedrig angesetzt..
Wäre der Kurs nur auf 3,75$ gestiegen hätte es eine ganz andere Resonanz gegeben.
Ich denke viele große Firmen haben Interesse an ALTIs Technologie(n) bekundet und es gibt in Zukunft bestimmt noch mehr Kapitalerhöhungen, was denkst du/ihr?
Dieser Satz ist mir eben nochmal besonders ins Auge gesprungen:
"Our research in battery electrode materials is a further indication of how Altair's scientists are able to apply their nanomaterials science knowledge to solving real world needs," commented Altair CEO Dr. Alan J. Gotcher. "Many of the technology and product development initiatives that we have been working on for the last few years are now coming to the commercialization stage. Each step is another validation of our business strategy and product technology platform. Altair's nanomaterial based, micro porous electrode technology has performance and stability advantages that appear to be unmatched when compared to the best commercialized technology in the market today."
..das heißt doch, dass dies erst der Anfang war und es noch viel mehr Einsatzbereiche mit ALTI Technik gibt, zum Beispiel Solarzellen usw.
Vielleicht warten in diesem Jahr noch einige spannende Meldungen auf uns (!)
gruß codex
p.s.Glaubt ihr der Kurs driftet deutlich unter die 4$ Marke falls es in naher Zukunft keine News geben sollte? (Ich nicht..)
------------------------------------------------------------------------------------------------------
Die Technologie scheint mir sehr interessant für die HYBRIDTENIK im Kfz-Bau der Zukunft zu sein!
TOYOTA ist da ja heute auf diesem Gebiet schon führend! Hast du gewußt, daß T. 50% seines Gesamtgewinnes in die Weiterentwicklung der Hybridmotoren steckt?
(Im letzten Jahr wurden bereits 80.000 Fahrzeuge mit dieser Technik gebaut und in diesem Jahr plant man bereits 180.000 !!
Und je leistungsfähiger die Batterien werden, desto effizienter wird diese Zukunftstechnik!!
Ich spreche ALTAIR nicht ausgezeichnete Perspektiven ab, sondern bin nur mit der
derzeitigen "Vorgehensweise" an der Börse zur "Mittelbeschaffung" nicht einverstanden! Das erinnert mich an andere - bereits erwähnte Fälle - in denen viele Leute viel Geld verloren haben. (Zumindest "Mittelfristig")
Wer natürlich genug Kaptial hat und auch mal Verluste von ca 30 - 50 % über einen längeren Zeitraum verkraften kann - ist langfristig mit ALTAIR sicher gut beraten!
Butzel66
21.02.2005, 20:53
Heute - ohne die US-Börsen kein nennenswerter Handel!
Mal sehen, wohin "die Reise morgen geht"!;)
[KERN]Codex
22.02.2005, 02:47
Das mit Toyota wusste ich nicht :eek:
Naja ich blicke gespannt auf Donnerstag :)
Butzel66
22.02.2005, 07:54
Codex']Das mit Toyota wusste ich nicht :eek:
Naja ich blicke gespannt auf Donnerstag :)
------------------------------------------------------------------------------------------
Ja, danach wird man Altair sicher kurz- mittelfristig etwas besser einschätzen können.;)
Trüffelschwein
24.02.2005, 03:54
Wenn das Volumen wieder anzieht und die Tagestiefs ansteigen (letzteres war eigentlich gestern schon der Fall), kann man m.E. einen Zock mit SL bei 3.95 USD wagen.Ich war gestern abend leider unterwegs, sonst wäre ich eingestiegen. Es sieht so aus, als ob die nächste Aufwärtswelle in Angriff genommen würde.
http://bigcharts.marketwatch.com/charts/big.chart?symb=alti&compidx=aaaaa%3A0&ma=1&maval=20&uf=8&lf=1&lf2=8&lf3=32&type=4&size=2&state=11&sid=1198546&style=320&time=7&freq=1&comp=NO%5FSYMBOL%5FCHOSEN&nosettings=1&rand=6199&mocktick=1
Butzel66
24.02.2005, 08:58
Es sieht zwar gut aus - aber trotzdem nicht "Blind" werden!
In USA ist der Kurs nachbörslich noch von $ 4,86 auf $ 4,77 gefallen......!
(Wahrscheinlich sind für heute erst mal wieder Gewinnmitnahmen angesagt!!):)
[KERN]Codex
24.02.2005, 17:12
Company Reports Significant Revenue Growth
RENO, NV--(MARKET WIRE)--Feb 24, 2005 -- Altair Nanotechnologies, Inc. (NasdaqSC:ALTI - News) today reported financial results for its fourth quarter and year ended December 31, 2004.
The company reported revenue of $511,003 for the fourth quarter of 2004, a considerable increase when compared to revenue of $30,822 for the fourth quarter of fiscal 2003. The net loss for the fourth quarter 2004 was $1.7 million or a loss per share of $0.03, as compared to a net loss of $2.3 million, or a net loss per share of $0.06 for the fourth quarter in 2003. :)
Operating expenses for the fourth quarter ended December 31, 2004 were approximately $2.18 million, down slightly when compared to operating expenses for the fourth quarter in 2003 of approximately $2.24 million.
For the year ended December 31, 2004, the company reported revenue of approximately $1.2 million, with a net loss of $7.0 million, or a net loss per share of $0.14, as compared to revenue for the year ended December 31, 2003 of approximately $73,000, with a net loss of $6.2 million, or a net loss per share of $0.19.
Operating expenses for the year ended December 31, 2004, were approximately $8.0 million, compared to operating expenses for the year ended December 31, 2003 of approximately $5.9 million.
Altair CFO Edward Dickinson noted, "Our net cash used in operations has averaged $468,000 per month during 2004 and $506,000 during the fourth quarter of 2004. We manage R&D costs and G&A expenses carefully and plan some increases in 2005 for expansion of our Life Sciences R&D projects and alternative energy initiatives as well as additional expenses associated with compliance with Sarbanes-Oxley requirements." :)
As of February 16, 2005, Altair`s balance sheet was strong, with a cash position of approximately $31.0 million compared to $3.9 million at December 31, 2003. The increase is due in part to the exercise of warrants and employee options during 2004 and 2005, and the sale of five million shares of the company`s common stock during February 2005. Altair`s long-term debt consists only of a promissory note of $3.0 million to purchase the land and building that houses the company`s 80,000-square-foot corporate headquarters, research and development laboratories and pilot plant facilities in Reno, Nevada. Under the terms of the promissory note, interest begins accruing in August 2005 with the first payment due February 2006. :)
Please join Altair`s management for a financial results and project update conference call today, February 24, 2005 at 11:00 AM Eastern. The dial-in number is 888.245.7013.
CONSOLIDATED BALANCE SHEETS
(Selected Financial Data Unaudited)
December 31, December 31,
2004 2003
------------ ------------
ASSETS
Total Current Assets $ 8,040,037 $ 3,962,180
Property, Plant and Equipment, net 6,513,907 6,618,805
Patents, net 974,877 1,060,569
Other Assets 18,200 18,200
------------ ------------
Total Assets $ 15,547,021 $ 11,659,754
============ ============
LIABILITIES AND SHAREHOLDERS` EQUITY
Total Current Liabilities $ 376,773 $ 397,141
Note Payable, Long-Term Portion 2,880,311 2,686,130
Total Shareholders` Equity 12,289,937 8,576,483
------------ ------------
Total Liabilities and Shareholders` Equity $ 15,547,021 $ 11,659,754
============ ============
ALTAIR NANOTECHNOLOGIES INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Selected Financial Data Unaudited)
Three Months Ended Twelve Months Ended
Dec. 31, Dec. 31,
2004 2003 2004 2003
---------- ---------- ---------- ----------
Revenues $ 511,003 $ 30,822 $1,151,892 $ 72,851
Total Operating Expenses 2,183,853 2,241,911 8,056,847 5,858,061
---------- ---------- ---------- ----------
Loss from Operations 1,672,850 2,211,089 6,904,955 5,785,210
Other (Income) Expense: 24,317 45,794 97,325 452,729
---------- ---------- ---------- ----------
Net Loss 1,697,167 2,256,883 7,002,280 6,237,939
Preferential Warrant
Dividend - - - 592,486
---------- ---------- ---------- ----------
Net Loss Applicable
to Shareholders $1,697,167 $2,256,883 $7,002,280 $6,830,425
========== ========== ========== ==========
Loss per Common Share
- Basic and Diluted $ 0.03 $ 0.06 $ 0.14 $ 0.19
========== ========== ========== ==========
Weighted Average Shares
- Basic and Diluted 49,499,735 40,809,605 48,677,283 36,222,026
========== ========== ========== ==========
ALTAIR NANOTECHNOLOGIES REPORTS PROJECT UPDATE IN PREPARATION FOR YEAR END RESULTS ANNOUNCEMENT
RENO, NV – February 23, 2005 – Altair Nanotechnologies, Inc. (NASDAQ: ALTI), today provided a Company Projects Update in preparation for its financial results conference call scheduled Thursday, February 24, 2005. Management believes that it would be beneficial to provide a project update so that investors will have an opportunity to review this information prior to the call.
" This has been a solid year of performance for the company," commented Altair Nanotechnologies CEO Alan J. Gotcher, Ph.D. " We have made progress in the transition to an emerging growth stage nanotechnology company with revenue from sales of a variety of products. Altair has signed licensing agreements with Western Oil Sands for pigment product technology, Spectrum Pharmaceuticals for nanotechnology based phosphate binding drugs (signed in January 2005) and entered into commercial collaborations for the development of enabling electrode product technology for a new titanium manufacturing process with Titanium Metals Corporation, the second largest producer of titanium metal in the world. We are making significant advancements on many fronts and plan to discuss our progress during the conference call."
Altair Nanotechnologies Corporate Update for 2004
Altair strengthened its management team, Board of Directors and Scientific Advisory Board and increased its cash holdings:
- The Company appointed Dr. Alan J. Gotcher, Ph.D., as CEO and member of the Board of Directors. Roy Graham was named Senior Vice President of Sales and Marketing on January 7,2005
- Altair increased the number of independent members of its Board of Directors adding David King, Ph.D., President, Advanced Technology Group, Michel Bazinet, M.D., CEO of Replicor and Christopher Jones, Ph.D., Senior Vice President, Behr Coatings.
- Altair expanded its Scientific Advisory Board to include Ravi Thadhani, M.D., a well known kidney dialysis research specialist, and Michael Graetzel, Ph.D., a renowned alternative energy expert.
- On February 14, 2005, Altair raised approximately $20 million through the sale of five million shares of its common stock. Proceeds are expected to be used for increased working capital, capital expenditures, research and development activities and acceleration of our commercial development activities.
- Management is hosting a financial results conference call February 24th at 11:00 AM Eastern. The dial-in number is 888.245.7013.
Life Sciences Division Update for 2004
The division entered into licensing negotiations on its first product technology, continued to develop intellectual property and began discussions with market partners to license additional product technology:
Pharmaceutical Products
RenaZorb™ Products - Nanotechnology-based Drug Candidate for Phosphate Binding in End Stage Renal Disease
- Altair's RenaZorb represents a second-in-class, lanthanum-based drug candidate for phosphate control in patients with end-stage renal disease (ESRD).
- January 31, 2005, Altair signed a licensing agreement with Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) giving them the exclusive worldwide rights to develop, market and sell RenaZorb for human therapeutic and diagnostic applications.
Drug Delivery Products
TiNano® Spheres™ Drug Delivery Systems
- TiNano Spheres are hollow, porous, high surface area, ceramic microstructures proposed for use in drug delivery systems. These systems have demonstrated high levels of drug and chemical loading and rapid drug and chemical release.
- Two patent applications have been filed for the drug delivery technology platform.
- Research and development efforts continue and discussions have begun to license this product technology to market partners.
Dental Nano-materials
- Altair continues to work with a research consortium sponsored by the National Institutes of Health to strengthen polymer-based dental fillings utilizing Altair's nano-zirconia.
Performance Materials Division Update for 2004
The division licensed pigment and electrode product technologies, advanced several companies towards licensing agreements and made substantial progress in the development of new product technology:
Advanced Materials for Paints, Coatings and Sensors
Titanium Dioxide Pigment – Altair's Hydrochloride Pigment Process (AHPP)
- Altair has successfully completed 50 percent of Phase l of the Western Oil Sands project to manufacture TiO2 pigment from tar sand tailings.
- Discussions progressed with a number of companies which may lead to new licensing agreements in 2005.
- January 25, 2005, Altair was awarded a new patent covering " Processing Aqueous Titanium Solutions to Titanium Dioxide Pigment" by the Australian Patent Office.
Advanced Ceramic Materials for Coatings
- Altair was awarded a third contract from a (confidential) Fortune 100 company to supply testing quantities of specialized nano-sized materials for coatings.
Advanced Ceramic Materials for Sensors
- Western Michigan University and Altair received a $2 million contract from DOE for joint development of nanosensors for detecting chemical and biological weapons. Under terms of the Stage ll contract scheduled to commence this quarter, Altair will receive $672,000 over a two-year period for collaborative research and development as a subcontractor.
Air and Water Purification Systems
Altairnano TiHPC Products for Photocatalysis
- Altair is partnering with Genesis Air to develop specialized surface activated nano-sized titanium dioxide compounds for use in HVAC air cleaning systems, specifically Genesis Air's Photocatalysis technology.
NanoCheck™ Products for Binding Phosphate in Water
- Independent and in-house laboratory testing has shown that Altair's unique nano-structured compound, NanoCheck, safely and effectively removes phosphate from water, preventing algae growth in swimming pools and reducing the quantity of chemicals currently required for algae prevention.
- Field testing, focused on evaluating NanoCheck's effectiveness in providing an algae-free environment for swimming pools, was delayed due primarily to hurricanes in the field testing areas. Testing has been reinitiated and results will be made public when available. Negotiations with major pool chemical companies for licensing of the product are moving forward.
Advanced Materials for Improving Process Technologies
Titanium Metal Manufacturing via Electrolysis Processing
- Altair's development agreement with Titanium Metals Corporation (NYSE:TIE), provides Altair the opportunity to supply enough TiO2 micro porous electrodes to produce 50 pounds of titanium metal per day to meet the DARPA titanium project goals as outlined by the program. The project has met its goals and Altair is currently producing materials to order.
High Performance Materials for Alternative Energy
Lithium Ion Battery Electrode Development
- Altair has completed research work under a $100,000 SBIR Phase l grant and has applied for a $500,000 SBIR Phase ll grant from the U.S. National Science Foundation to continue work on carbon-coated, nano-structured electrodes for next-generation lithium-ion ultra capacitors with partners Hosokawa Micron and Rutgers University.
- Altair was allowed two U.S. patents for the manufacturing of products used in the development of lithium ion batteries and super capacitors. The first patent describes a " Process For Making Lithium Titanate" , and the second patent describes a " Process For Making Nano-sized and Sub-micron-sized Lithium-Transition Metal Oxides" .
- Altair is introducing its battery materials to battery manufacturers. These materials have the capacity to enable a new generation of rechargeable battery with three times the power of existing Lithium Ion batteries, the capability of recharging in minutes instead of hours and increased battery life.
Hydrogen Generation using Solar Energy
- University of Nevada, Las Vegas, Altair and Hydrogen Solar, LLC were awarded a $3,000,000 U.S. Department of Energy grant to pursue joint research activities related to solar hydrogen production using solar energy at a refilling station that is under development in Las Vegas. Vehicle integration, testing and demonstration are included in the project demonstration.
Thermal Spray Grade Powders
- Thermal Spray powders have use in a variety of harsh environmental applications such as aerospace propulsion systems, blades and vanes, medical applications, boilers, incinerators, and oil and gas industry uses. During the first quarter of 2004 the National Research Council completed its report evaluating the Altair thermal spray powders. The report concluded that Altair's thermal spray powders were more abrasion resistant than conventional powders. We continue to supply sample quantities for customer testing.
gruß codex
Altair haben Nanotechnologie-Materialien zur Herstellung eines Prototypen einer Polymer-Lithium-Batterie an Advanced Battery Technologies ausgeliefert.
Die strategische Allianz zwischen ALTI und Advanced Battery wurde am 4. April 2005 bekannt gegeben.
Sind Altair Nanotechnologies und Altair Engineering eigentlich der gleiche Laden?
Engineering macht in Softwarelösungen...
@Auge
So wie sich das Profil von Altair Nanotechnologies liest, handelt es sich wohl um zwei unterschiedliche Firmen.
Altair Nanotechnologies, Inc. engages in developing and commercializing nanomaterial and titanium dioxide pigment technologies. It also provides contract research services on select projects to develop intellectual property and/or new products and technology. The company operates in two segments, Performance Materials and Life Sciences. The Performance Materials segment produces materials for paints, coatings, thermal spray powders, photocatalytic materials for air and water cleansing, sensors, power systems, materials for improving process technologies, and alternative energy devices, such as high performance batteries, fuel cells, and photovoltaics. The Life Sciences segment produces pharmaceutical products, including lanthanum-based active pharmaceutical ingredients; drug delivery products for the delivery of chemicals, drugs, and biocides; and biocompatible nanomaterials for use in dental implants, dental fillings, and dental products, as well as in biocompatible coatings on implants. The company was founded in 1973 as Diversified Mines Limited and changed its name to Tex-U.S. Oil & Gas, Inc. in 1981. Later, it changed its name to Orex Resources, Ltd. in 1986; to Carlin Gold Company, Inc. in 1988; to Altair International Gold, Inc. in 1994; to Altair International, Inc. in 1996; and to Altair Nanotechnologies, Inc. in 2002. The company is headquartered in Reno, Nevada.
the mind
17.01.2007, 01:17
so wie sich das profil von ALTI liest, handelt es sich wohl in wenigen jahren wieder um eine firma anderen namens, die versucht auf einen neuen trend aufzuspringen. :chin:
Mr.Brown
07.02.2007, 18:36
Hi,
ich glaube Altair fängt gerade an die ersten Nano-LiIons in Serie herzustellen. Dazu gibt es eine Kooperation mit (hab´s gerade vergessen..) einem amerikanischen Automotive-Entwickler um einen EV-Prototyp (electric vehicle) zu bauen. Ein Demonstrator sozusagen der dann andere Fahrzeughersteller für grosse OEM-Volumen anzieht.
Der Kurs zieht sich auch erstaunlich nach oben, kontinuierlich von Tag zu Tag.
Gruss, Mr.Brown
Mr.Brown
07.02.2007, 19:10
der Kurs läuft wie eine Treppe in den USA... dazu steigende Umsätze in den letzen Tagen... ähnliches hierzulande.
Baue mal spekulativ eine kleine Position auf.
Gruss, Mr.Brown
edit: KK 2,38 EUR
Mr.Brown
27.02.2007, 09:39
okay, erste Zwischenbilanz:
die News sind gut: http://www.b2i.us/profiles/investor/ResLibraryView.asp?ResLibraryID=18474&GoTopage=1&BzID=546&Category=987
die Batteriehersteller wie A123 als auch Altair gehen nun reihenweise
strategische Partnerschaften mit Automotive Corporates ein. Altair
liefert sogar schon erste Stacks gegen Bezahlung aus. Für mich ein gutes Zeichen.
KK war 2,38
heute: Frankfurt 2,61 also fast 10%
bleibe weiter optimistisch. Vorsicht sollte man gegenüber Meldungen von EEStor walten lassen. Die Probleme mit hochreinen TiO für spezielle Supercaps sind noch nicht gelöst. Solange sind auch meine Bedenken für Batteriehersteller gering. Ein Auge sollte man auf die Supercap-Industrie jedoch behalten.
Gruss, Mr.Brown
Mr.Brown
13.03.2007, 17:00
RENO, NV – March 8, 2007 – Altair Nanotechnologies Inc. (Nasdaq: ALTI), a leading provider of advanced nanomaterials technology for use in energy, pharmaceutical, life sciences and industrial applications, today reported financial results for its year ended December 31, 2006.
For the year, revenues increased 54 percent to $4.32 million from $2.81 million in 2005. The net loss for the year was $17.20 million or 29 cents a share, compared to a net loss of $9.94 million or 17 cents a share, in the prior year.
Operating expenses of $22.01 million for 2006 were $8.72 million greater than operating expenses of $13.29 million for 2005. Increased operating expenses were due to greater research and development efforts, expenses of approximately $5.00 million, largely for staffing and other expenditures related to battery development; increased sales and marketing expenses of approximately $0.34 million primarily relating to increased marketing efforts in the AMPS division; and increased general and administrative (G&A) expenses of approximately $1.92 million. The G&A increase was primarily due to share-based compensation expense, a non-cash item, which increased by approximately $1.54 million, as a result of implementing SFAS 123R as of January 1, 2006.
"This past year represented a major turning point for Altair Nanotechnologies as we took our first steps toward commercialization," said Alan J. Gotcher, Ph.D., President and Chief Executive Officer of Altair Nanotechnologies Inc. "We accepted and delivered on our first order from Phoenix Motorcars, to provide our proprietary NanoSafe™ battery packs for their all-electric Sports Utility Trucks. We believe this is a major step forward in realizing the commercial promise of all-electric zero emission vehicles."
Altairnano's balance sheet remains strong, with cash and short-term investments totaling $27.22 million at year end. The Company's debt, from a mortgage obligation on its 100,000 square feet of offices, laboratories and semi-works facilities in Reno, Nevada, was $2.40 million on December 31, 2006.
"We continue to invest in our Advanced Materials and Power Systems (AMPS) business unit, which accounted for a significant portion of our increased expenses during 2006. During the first quarter of 2007 we received a purchase order from Phoenix Motorcars for $1.04 million of our NanoSafe battery packs to be delivered in the first quarter and projections for total 2007 orders between $16 and $42 million. We will continue to make strategic investments in our battery materials, batteries and battery systems, which we believe have a potential for strong returns and serve as a major driver for our business," Gotcher said.
Source: Altair Nanotechnologies
kurz: 54% Umsatzplus, knapp 80% mehr Verlust pro Aktie (vgl. mit 2005), gute Aussichten durch erstes Serieneinsatz bei Pheonix Motorcars in U.S.
Frankfurt: 2,41 EUR aktuell
Mr.Brown
19.03.2007, 21:21
Hallo,
hier ein spannendes Interview mit CEO Allan Gotcher:
http://www.insidegreentech.com/node/784
Interessant auch der Verlgeich: Kosten Wasserstoff / Electric Infrastruktur und die Angabe, dass Altair bei Pheonix Motor Corp. direkt eingestiegen ist.
ALTI aktuell: 2,50EUR
Gruss, Mr.Brown
Mr.Brown
22.04.2007, 12:26
Altair: Nano Pretender No More
Josh Wolfe, Forbes/Wolfe Nanotech Report 04.05.07, 11:22 AM ET
If you're a nanostock enthusiast as well as a regular Forbes Wolfe Nanotech Report reader, there's no doubt you're familiar with Altair Nanotechnologies (nasdaq: ALTI - news - people ). The tiny Reno, Nev.-based company is a manufacturer of ceramic nanomaterials such as yttria-stabilized zirconia, titanium dioxide and alumina, and lithium titanate for myriad applications as drug delivery agents, thermal barrier coatings and as electrodes in high-power batteries and power systems.
Altair (other-otc: ATCD - news - people ) has been in the news recently for its application of lithium titanate spinel oxide nanocrystals for electric batteries, branded NanoSafe. The company claims that it has achieved several orders of magnitude improvement in charging time and battery life cycle.
In fact, President Bush recently inspected an all-electric battery-powered truck produced by Phoenix Motorcar, featuring Altair's NanoSafe power system. The president peered under the hood and said the vehicle was "living proof" of how America would lower gasoline consumption by 20% in 10 years. ALTI rocketed 18% over the next seven trading days.
This White House demonstration was no mere public relations stunt. Altair seems to be making progress in getting real nanomaterials-based products to market, with its NanoSafe batteries in particular. Altair has an exclusive three-year deal as supplier of high-power electric batteries to Phoenix Motorcar. It also has a 16% ownership stake in Phoenix.
The company has closed some impressive partnerships and supplying agreements of late, including deals with aluminum giant Alcoa (nyse: AA - news - people ) and Pacific Gas & Electric (amex: PCG.PR.A - news - people ), both of which are buying Phoenix's vehicles for use as delivery vans. Altair also partnered with pharmaceutical major Eli Lilly (nyse: LLY - news - people ), which is licensing Altair's phosphate build-up prevention drug, branded Renalan, for its animal health care division.
However, W.R Hambrecht's John Roy, who covers the stock, revealed that a development partnership with Flushing, N.Y.-based Advanced Battery Technology had all but fizzled out.
Though the dollar amounts for the concluded deals are small, they represent significant breakthroughs for Altair. Besides high-power batteries and pharmaceuticals, Altair is targeting applications for its ceramic nanomaterials in high-performance coatings, electronic components and certain catalysts and pigments. The company maintains a strong R&D focus, and has over 20 U.S. and 47 international patents filed for or granted, relating to processing and production techniques for the various ceramic materials it manufactures.
In May 2002, I called Altair a "Nano Pretender" noting that it had changed names more often than Oprah's clothes, in trying to carefully cultivate an image of a nanotech company in name if not in practice. In May 2006, I wrote about the restructuring of the company, noting the positive changes instituted by CEO Alan Gotcher since he took over in September 2004. Gotcher has given Altair much more focus.
Altair has realized quickly that the way to prosper this cutthroat arena is to develop a diverse portfolio of products. It now targets different industries such as batteries, electronic components, pharmaceuticals and drugs, and chemicals and coatings.
Altair's key product is its NanoSafe high-powered battery. But another nano battery maker, MIT spinoff A123 Systems, has closed partnerships and supplying deals with giants such as General Motors (nyse: GM - news - people ) and Black & Decker (nyse: BDK - news - people ). Why work with A123's technology over Altair's? Altair is tied up with Phoenix, which has an exclusive supply agreement. Hambrecht's John Roy said that Altair's revenue will be driven by its deal with Phoenix, which itself was facing a cash crunch. Indeed, Phoenix admits it had hired an investment bank to scout for investors.
In contrast, Watertown, Mass.-based A123 has raised more than $100 million in funding since inception, with the most recent round led by names such as General Electric (nyse: GE - news - people ) and the Duracell unit at Procter & Gamble (nyse: PG - news - people ). It has received backing from DaimlerChrysler (nyse: DCX - news - people ) and Ford (nyse: F - news - people ), and GM is providing funding support through a group called the U.S. Advanced Battery Consortium. Clearly, big business prefers A123 to Altair.
Recently, though, power generation and distribution giant AES bought a strategic 1.5% stake in Altair for $3 million citing the game-changing potential of the company's battery business. Once Phoenix is able to secure the funding it needs, Altair's revenue could grow fast. Larger orders for its batteries should increasingly bring down unit production costs, making Altair's technology more cost-competitive. Phoenix should obtain funding by Q2, with orders for Altair's batteries ramping up in Q3 and finally the results coming in Q4.
Since the beginning of the year, traders have pushed up ALTI's shares 26%. Fundamentally, Altair is much stronger today than when I first looked at the company. Altair has $15 million on its balance sheet in cash and liquid investments. Phoenix has already placed orders worth $1 million for Q1, but its funding problems have WR Hambrecht concerned. It has lowered its 2007 revenue estimates from $32.9 million to $21.2 million.
According to Phoenix, its zero emission or "green" electric vehicles won't be available to consumers until 2008, though it expects to sell 500 or so this year. W.R. Hambrecht forecasts revenues of $42.2 million for 2008, and rates the stock a "buy" with a price target of $5.50. Insiders have been acquiring shares since May last year.
Altair's business model currently depends heavily on its integrated approach to commercializing high-power batteries. If Phoenix cars are in high demand and it is efficient at manufacturing, Altair will prosper. But Phoenix's petite tree-hugging trucks will not replace Ford's best-selling F-150 pick-up overnight. Eventually Phoenix's success translates into more battery orders for Altair--but Altair is heavily dependent on Phoenix for its revenues for at least the next two years.
Altair's strategy concentrates risk. A123 is taking a more traditional component-supplier approach similar to Microsoft's (nasdaq: MSFT - news - people ) strategy of licensing its operating system to third-party computer manufacturers and assemblers. But Altair's success depends on Phoenix. If Phoenix's vehicles are not successful, Altair is doomed to become an also-ran. In my book, this is a risky bet to make given that A123 is partnering with big automakers as well as GE and P&G.
Altair has come a long way since my 2002 Nano Pretender article. It is now a bona fide player in the exciting nano-enabled battery market. I take my hat off to the progress and focus that CEO Gotcher has brought to the company and will keep a close eye on Altair. But alas, I am not yet ready to open up my wallet to buy shares of ALTI. President Bush peers inside a Phoenix Motorcar.
Josh Wolfe is editor of the Forbes Wolfe Nanotech Report. Click here for more of his analysis of the evolving nanotechnology sector.
Mr.Brown
10.10.2007, 11:21
Hallo,
trotz dass der alte ALTI Thread verloren ging...(?)
Nach meiner Ansicht ist die Batterietechnologie durch die zunehmende Kommerzialisierung der Nanosafe Batterien von ALTI auf gutem Weg ein Standart-Produkt für zukünfitge mobile elektr. Anwendungen zu werden.
Kein anderen Hersteller kann mit derartigen Ladegeschwindigkeiten (10min bei >100kW!!!) und höher Zyklenzahl (>20.000) aufwarten. Trotz leicht geringerer Energiedichte ist die Leistungsdichte ca. 4-5 mal höher als die der Wettwerber und die Sicherheitsprobleme sind gelöst (Vgl. herkömmliche Li-Iion arbeiten bis ca. 130°C vs. 250°C bei Altair).
Erreicht werden diese Daten durch den Einsatz einer nano-strukturierten Lithium-Titanat-Elektrode auf der negativen Zellseite anstelle der herkömmlichen Graphitelektroden.
Würde mich über eine Diskussion zum Thema Batterien freuen.
Viele Grüße,
Mr.Brown
Trüffelschwein
10.10.2007, 11:24
Guck mal hier:
http://www.aktienboard.com/vb/showthread.php?p=1796752#post1796752
Trüffelschwein
10.10.2007, 11:28
Hier an Board geht nichts verloren. Hoch mit dem Thread!
Mr.Brown
10.10.2007, 13:34
Cool, wie hast du das gemacht???
Habe die Threads zusammengeführt.
@Mr. Brown
Über die Forensuche kannst du Threads finden: http://www.aktienboard.com/vb/showthread.php?t=90991
Mr.Brown
19.10.2007, 14:52
Hallo Aktienboarder,
für die die gar nicht wissen warum Altairnano so interessant ist im Vergleich zu anderen Li-Ionen Herstellern...
also Altair besitzt know-how im Bereich Lithiumtitanat für die Industrie. Außerdem ist man in der Lage durch sintern und mahlen nanoporöses Lithiumtitanat herzustellen welches Obeflächen von ca. 70m² pro Gramm besitzt.
Außerdem ist Lithiumtitanat ein sog. "zero-stress" Material welches die Einlagerung von Li-Ionen ohne Volumenänderung ermöglicht wodurch widerum das Aktivmaterial nicht zerstört wird wie bei anderen Varianten. Zudem entfällt Graphit welches mit dem Elektrolyt reagieren kann und zum berüchtigten Thermal Runaway führt das sehr viel Hitze freigesetzt wird. Das Lithiumtitanat hat noch ein spezielles Coating damit es sich nicht so schnell abbaut (wegen der nun größeren Fläche). Durch Einsatz guter Elektrolyten funktioniert das ganze sogar bei extremen Minus- und Plusgraden, was wie ich finde grundlegend ist für den Einsatz in Fahrzeugen.
soweit, ein schönes WE - Mr.Brown
Bin hier mit einer kleinen Position investiert, seit 6 Monaten deutliche Abschläge.
Die seit mehreren Monaten aufgenommene Seitwärtsbewegung sollte eigentlich eine fundierte Bodenbildung sein. Meiner Meinung nach reif für Anstieg auf bis 3,4 (leider kann ich keinen Chart anhängen)
Was meinen die Profis?
Beste Grüsse
El Cid